Magnetic resonance imaging of the brain may help physicians predict patient outcomes following a cardiac arrest.
Determining MR imaging-based measures of the brain within two weeks of a patient’s cardiac arrest may help physicians predict patient clinical outcomes, according to a study published in Radiology.
Researchers from the United States and France performed a prospective multicenter study to assess whether early brain functional connectivity is associated with functional recovery one year after cardiac arrest.
Forty-six patients who were comatose after a cardiac arrest were enrolled in the study. The principle outcome was cerebral performance category at 12 months. A favorable outcome was defined as cerebral performance category 1 or 2.
All participants underwent multiparametric structural and functional MR imaging less than 4 weeks (mean of 12.6 days) after their cardiac arrest. Using seed-based analysis of resting-state functional MR imaging data, within- and between-network connectivity was measured in:
• Dorsal attention network (DAN)
• Default-mode network (DMN)
• Salience network (SN)
• Executive control network (ECN)
Structural changes identified with fluid-attenuated inversion recovery and diffusion-weighted imaging sequences were analyzed by using validated morphologic scales. The association between connectivity measures, structural changes, and the principal outcome was explored with multivariable modeling.
The results showed at 12 months, 11 patients had a favorable outcome. Patients with favorable outcome had higher within-DMN connectivity and greater anticorrelation between SN and DMN and between SN and ECN compared with patients with unfavorable outcome, an effect that was maintained after multivariable adjustment. Anticorrelation of SN-DMN predicted outcomes with higher accuracy than fluid-attenuated inversion recovery or diffusion-weighted imaging scores.
The researchers concluded that using MR imaging to measure cerebral functional network connectivity obtained in the acute phase of CA were independently associated with favorable outcome at one year. The authors suggested that these findings warranted validation as early markers of long-term recovery potential in patients with anoxic-ischemic encephalopathy.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.
FDA Expands Clearance of MRI-Guided AI Platform for Deep Brain Stimulation and Lesioning Techniques
September 3rd 2024Utilizing a new machine learning model, the OptimMRI software may improve radiosurgery applications and lesioning techniques such as MRI-guided focused ultrasound through enhanced targeting of the inferolateral part of the ventral intermediate nucleus (VIM).